- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
The U.S. District Court for the District of Delaware on Wednesday (June 16) rejected the Biden administration’s request to dismiss AstraZeneca’s lawsuit challenging HHS’ effort to stop drug maker restrictions on 340B discounts on drugs dispensed via contract pharmacies, as the judge said the statue is vague on the issue.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us